v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2024
Jun. 30, 2023
Current assets    
Cash $ 661,415 $ 4,492,292
Accounts receivable, net 606,885 1,125,394
Inventory, net 1,431,556 4,804,299
Due from Bloomios 0 845,443
Due from VitaMedica transition 212,358 0
Prepaid expenses and other receivables 502,188 1,112,280
Assets available for sale - Interactive offers current 0 89,989
Assets available for sale - Building 4,005,516 4,611,248
Assets available for sale - VitaMedica current 0 2,599,934
Assets available for sale - E-core current 0 10,332,105
Purchase price receivable - VitaMedica 2,000,000 0
Purchase price receivable - E-core 2,000,000 0
Total current assets 11,419,918 30,012,984
Property and equipment, net 2,356,556 2,831,375
Intangible assets, net 239,871 6,924,982
Goodwill 848,854 2,886,309
Deferred tax asset 5,948,858 5,604,056
Other assets 278,435 76,728
Discontinued assets available for sale - Interactive offers 0 936,054
Discontinued assets available for sale - VitaMedica 0 2,051,214
Discontinued assets available for sale - E-core 0 12,067,333
Right-of-use asset, net 2,418,596 410,453
Total other assets 12,091,170 33,788,504
Total assets 23,511,088 63,801,488
Current liabilities    
Accounts payable 481,647 1,028,611
Accrued compensation 1,098,856 533,842
Deferred revenue 235,255 0
Accrued liabilities 736,407 2,439,794
Accrued interest 476,018 655,187
Acquisition payable 413,152 152,500
Related party advances, net 100,000 0
Current portion of note payable 0 338,474
Current portion of convertible notes payable 0 1,254,167
Current portion of acquisition note payable - E-core 0 5,656,620
Current portion of related party note payable 0 1,429,356
Current portion of Cygnet subsidiary notes payable 5,447,565 795,778
Note payable on building for sale 2,634,538 2,841,566
Discontinued liabilities - Interactive offers 0 792,408
Discontinued liabilities - VitaMedica 0 617,174
Discontinued liabilities - E-core 0 3,401,983
Current portion of operating lease payable 1,031,714 454,127
Total current liabilities 12,655,152 22,391,587
Operating lease payable, net of current portion 1,732,606 0
Related party note payable 500,000 0
Note payable 557,429 173,812
Convertible notes payable 1,550,000 895,833
Acquisition note payable - E-core 0 7,605,085
Notes payable - Cygnet subsidiary 0 4,898,548
Total long-term liabilities 4,340,035 13,573,278
Stockholders' equity    
Preferred stock, $0.001 par value, 500,000 shares authorized, and 25,000 and 25,000 shares issued and outstanding, respectively 25 25
Common stock, $0.001 par value, 5,000,000 shares authorized, and 1,010,843 and 1,045,429 shares issued and outstanding, respectively 1,045 1,011
Additional paid in capital 53,374,444 51,541,909
Accumulated deficit (46,859,613) (23,201,175)
Total stockholders' equity attributable to Upexi, Inc. 6,515,901 28,341,770
Non-controlling interest in subsidiary   (505,147)
Total stockholders' equity 6,515,901 27,836,623
Total liabilities and stockholders' equity $ 23,511,088 $ 63,801,488